NDC 72934-1055

CLINDAMYCIN 1% / SODIUM SULFACETAMIDE MONOHYDRATE 5% / TRETINOIN 0.025%

Clindamycin 1% / Sodium Sulfacetamide Monohydrate 5% / Tretinoin 0.025%

CLINDAMYCIN 1% / SODIUM SULFACETAMIDE MONOHYDRATE 5% / TRETINOIN 0.025% is a Topical Gel in the Human Prescription Drug category. It is labeled and distributed by Sincerus Florida, Llc. The primary component is Clindamycin Phosphate; Sulfacetamide Sodium; Tretinoin.

Product ID72934-1055_88017b99-00e8-5476-e053-2a95a90a66a7
NDC72934-1055
Product TypeHuman Prescription Drug
Proprietary NameCLINDAMYCIN 1% / SODIUM SULFACETAMIDE MONOHYDRATE 5% / TRETINOIN 0.025%
Generic NameClindamycin 1% / Sodium Sulfacetamide Monohydrate 5% / Tretinoin 0.025%
Dosage FormGel
Route of AdministrationTOPICAL
Marketing Start Date2019-05-04
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameSincerus Florida, LLC
Substance NameCLINDAMYCIN PHOSPHATE; SULFACETAMIDE SODIUM; TRETINOIN
Active Ingredient Strength1 g/100g; g/100g; g/100g
Pharm ClassesDecreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [CS],Sulfonamide Antibacterial [EPC],Sulfonamides [CS],Retinoid [EPC],Retinoids [CS]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 72934-1055-2

30 g in 1 BOTTLE, PUMP (72934-1055-2)
Marketing Start Date2019-05-04
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 72934-1055-2 [72934105502]

CLINDAMYCIN 1% / SODIUM SULFACETAMIDE MONOHYDRATE 5% / TRETINOIN 0.025% GEL
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-05-04

Drug Details

Active Ingredients

IngredientStrength
CLINDAMYCIN PHOSPHATE1 g/100g

Pharmacological Class

  • Decreased Sebaceous Gland Activity [PE]
  • Lincosamide Antibacterial [EPC]
  • Lincosamides [CS]
  • Sulfonamide Antibacterial [EPC]
  • Sulfonamides [CS]
  • Retinoid [EPC]
  • Retinoids [CS]
  • Decreased Sebaceous Gland Activity [PE]
  • Lincosamide Antibacterial [EPC]
  • Lincosamides [CS]
  • Sulfonamide Antibacterial [EPC]
  • Sulfonamides [CS]
  • Retinoid [EPC]
  • Retinoids [CS]

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.